Stay updated on Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous funding/operating status notice (Revision: v3.4.1).SummaryDifference0.4%

- Check21 days agoChange DetectedA new banner informs users that information may not be up to date due to a government funding lapse and that the NIH Clinical Center is open, with a revision tag updated to v3.4.1. The page also lists recent revision dates (2026-01-12, 2026-01-28, 2026-12).SummaryDifference0.7%

- Check28 days agoChange DetectedAdded a Show glossary control and updated page metadata to include Last Update Submitted that Met QC Criteria and No FEAR Act Data. The site revision was updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section with Massachusetts as a site and updated the page revision to v3.3.3. The old 'Massachusetts Locations' label was removed and the HHS Vulnerability Disclosure link was deleted.SummaryDifference0.2%

- Check92 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not be about the study. The revision note shows the page updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.